Churg-Strauss syndrome

Annals of Allergy, Asthma and Immunology

Volumn 86, Issue 6, 2001, Pages 603-613

  Ramakrishna, G ^a   Midthun, D E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT;

CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; META ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0034979079     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62286-7     Document Type: Review

References (106)

1. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa
2. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases
3. Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg-Strauss syndrome
4. Neurologic manifestations of Churg-Strauss syndrome
5. Churg-Strauss syndrome in a district hospital
6. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients
7. Epidemiology of systemic vasculitis: Changing incidence or definition?
8. Churg-Strauss syndrome
9. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)
10. Allergic angiitis and granulomatosis. Prolonged remission induced by combined prednisone-azathioprine therapy
11. Churg-Strauss syndrome
12. Bronchoalveolar lavage in allergic granulomatosis and angiitis
13. Severe alveolar haemorrhage in Churg-Strauss syndrome
14. Churg-Strauss syndrome: The spectrum of pulmonary CT findings in 17 patients
15. Chronic eosinophilic pneumonia: CT findings in six cases
16. Chronic eosinophilic pneumonia: Evolution of chest radiograms and CT features
17. Churg-Strauss syndrome. Development of cardiomyopathy during corticosteroid treatment
18. Prominent pericardial and myocardial lesions in the Churg-Strauss syndrome (allergic granulomatosis and angiitis)
19. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report of an autopsy case in a nonasthmatic patient
20. Endomyocardial complications of the Churg-Strauss syndrome
21. Coronary involvement in the Churg-Strauss syndrome
22. Evolution to dilated cardiomyopathy from acute eosinophilic pancarditis in Churg-Strauss syndrome
23. Acute myocardial injury and repeated angina pectoris-like attacks in a young patient with Churg-Strauss syndrome
24. Myocardial involvement in Churg-Strauss syndrome: The role of endomyocardial biopsy
25. Cardiac manifestations of Churg-Strauss syndrome: Report of a case and review of the literature
26. The Churg-Strauss syndrome. A case report with angiographically documented coronary involvement and a review of the literature
27. Relation between eosinophilia and endomyocardial disease
28. Successful surgical treatment of two patients with eosinophilic endomyocardial disease
29. Churg-Strauss syndrome with right ventricular tumor
30. Churg-Strauss syndrome complicated by eosinophilic endomyocarditis
31. Thrombosis in Churg-Strauss syndrome. Beyond vasculitis?
32. Reversible monocular blindness complicating Churg-Strauss syndrome
33. Cardiac involvement in Churg-Strauss syndrome shown by echocardiography
34. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy
35. Allergic granulomatosis and granulomatous-vascular syndromes
36. Churg-Strauss syndrome presented as multiple intracerebral hemorrage
37. Vascular allergy: Pathogenesis of bronchial asthma with recurrent pulmonary infiltrations and eosinophilic polyserositis
38. Periarteritis nodosa and asthma
39. Ophthalmological and neuro-ophthalmological involvement in Churg-Strauss syndrome: A case report
40. Renal involvement in Churg-Strauss syndrome
41. ANCA-positive Churg-Strauss syndrome with renal failure
42. Cutaneous clinicopathologic correlation of allergic granulomatosis
43. The problem of allergic cutaneous vasculitis
44. Cutaneous lesions of allergic granulomatosis: Histopathologic study
45. Granulomatous vasculitides and the skin
46. Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation
47. The cutaneous extravascular necrotizing granuloma (Churg-Strauss granuloma) and systemic disease: A review of 27 cases
48. Perforation of small intestine caused by Churg-Strauss syndrome
49. Churg-Strauss syndrome diagnosed and followed with gastrointestinal fiberscopic studies and electroneuromyography
50. Churg-Strauss syndrome (allergic granulomatous angiitis) presenting with ileus caused by ischemic ileal ulcer
51. Churg-Strauss syndrome leading to small bowel infarction: An unusual case of abdominal pain in a young patient
52. Churg-Strauss syndrome with intestinal perforation
53. A case of Churg-Strauss vasculitis complicated by small bowel necrosis
54. A case of Churg-Strauss syndrome: Tissue diagnosis established by sigmoidoscopic rectal biopsy
55. Ureteral involvement in the Churg-Strauss syndrome: A case report
56. Ureteral stenosis secondary to Churg-Strauss allergic granulomatous vasculitis
57. Allergic granulomas of the prostate: Treatment with steroids
58. Allergic granulomatous vasculitis (Churg-Strauss syndrome). Report of a case with widespread digestive involvement
59. Allergic granulomatosis
60. Clinical features of fifteen patients with the hypereosinophilic syndrome
61. Toxic effects of human eosinophil products on isolated rat heart cells in vitro
62. Intimate association of eosinophils to collagen bundles in eosinophilic myocarditis and ranitidine-induced hypersensitivity myocarditis
63. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome-62 patients
64. Relationship between the development of blindness in Churg-Strauss syndrome and anti-myeloperoxidase antibodies
65. Crescentic glomerulonephritis and elevated antimyeloperoxidase antibody in a patient with Churg-Strauss syndrome
66. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): A Fc gamma RII-dependent process
67. Churg-Strauss syndrome: Serum markers of lymphocyte activation and endothelial damage
68. Serum interleukin-5 levels in a case with allergic granulomatous angiitis
69. Vasculitides associated with infections, immunization, and antimicrobial drugs
70. Churg-Strauss angiitis. Arguments favoring the responsibility of inhaled antigens
71. Ortset of polyarteritis nodosa during allergic hyposensitization treatment
72. Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels
73. Interaction of cells with immune complexes: Adherence, release of constituents, and tissue injury
74. Drug-related Churg-Strauss syndrome?
75. Cocaine-induced Churg-Strauss vasculitis
76. Macrolide-induced Churg-Strauss syndrome in a patient with atopy
77. Vasculitis with allopurinol therapy
78. Possibly thiazide-induced renal necrotising vasculitis
79. Carbamazepine-induced granulomatous necrotizing angiitis with acute renal failure
80. Necrotizing vasculitis associated with diphenylhydantoin: Two fatal cases
81. Phenytoin-induced systemic granulomatous vasculitis
82. Quinine induced granulomatous hepatitis and vasculitis
83. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial
84. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast
85. Churg-Strauss syndrome associated with zafirlukast
86. Churg-Strauss syndrome associated with zafirlukast
87. Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast
88. The role of cysteinyl leukotriene receptor antagonists in asthma therapy
89. Zafirlukast and Churg-Strauss syndrome
90. 5-Lipoxygenase inhibitory activity of zileuton
91. Zafirlukast, and Churg-Strauss syndrome
92. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment
93. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma
94. Formes frustes of Churg-Strauss syndrome
95. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast
96. Steroids and Churg-Strauss syndrome
97. Zafirlukast and Churg-Strauss syndrome
98. Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonists
99. Churg-Strauss syndrome during pregnancy after steroid withdrawal
100. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients
101. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients
102. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients
103. Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome. Indications of plasma exchanges, meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis
104. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome
105. Cyclosporin in the treatment of Churg-Strauss syndrome
106. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients